Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders.

Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer.

The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia.

Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia.

Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression.

Structures of Thymosin Proteins.

Molecular mechanisms and timing of cortical immune activation in schizophrenia.

Chemokine receptors and cortical interneuron dysfunction in schizophrenia.

Safety evaluation of intravenously administered mono-thioated aptamer against E-selectin in mice.

Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis.

Prehospital use of magnesium sulfate as neuroprotection in acute stroke.

Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance.

Thioaptamers targeting dengue virus type-2 envelope protein domain III.

Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia.

Cortical inhibitory neuron disturbances in schizophrenia: role of the ontogenetic transcription factor Lhx6.